Skip to main content
Signal8

Huizenga Theodore Alan

SEC insider (Form 3/4/5 filer). CIK 0001603347. SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE). 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in NOVATO, CA.

Companies Huizenga Theodore Alan has filed insider reports for

  • Ultragenyx Pharmaceutical Inc. (RARE): Officer, SVP, Chief Accounting Officer
Huizenga Theodore Alan profile photo

Huizenga Theodore Alan

CIK: 0001603347

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (57.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (21.4%)

Compensation grants

Other (G, F, J, C, D, …)3 (21.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ultragenyx Pharmaceutical Inc. logo
RARE

Ultragenyx Pharmaceutical Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Sep 15, 2026
    Sale
    Direct
    1.3K shares at avg. $13.57$17K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Sep 3, 2026
    Sale
    Direct
    161 shares at avg. $13.99$2K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Apr 22, 2026
    Award
    Direct
    20.2K shares-
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 2, 2026
    Tax Payment
    Direct
    148 shares at avg. $23.39$3K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 2, 2026
    Sale
    Direct
    1.6K shares at avg. $22.80$37K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Dec 29, 2025
    Sale
    Direct
    85 shares at avg. $34.38$3K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Sep 18, 2025
    Sale
    Direct
    64 shares at avg. $29.17$2K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Sep 5, 2025
    Sale
    Direct
    84 shares at avg. $31.39$3K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 3, 2025
    Sale
    Direct
    967 shares at avg. $42.10$41K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 3, 2025
    Tax Payment
    Direct
    141 shares at avg. $42.92$6K

1-10 of 14